Wnt/Catenin Signaling in Adult Stem Cell Physiology and Disease

Stem Cell Reviews and Reports

Volumn 10, Issue 4, 2014, Pages 512-525

  Ring, Alexander ^a   Kim, Yong Mi ^a   Kahn, Michael ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cancer; CBP; Co activator; CSC TIC; Differentiation and proliferation; EMT; Mode of division; p300; Somatic stem cells; Wnt

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ADULT; ADULT STEM CELL; CELL DIFFERENTIATION; CYTOLOGY; DISEASES; HUMAN; METABOLISM; PHYSIOLOGY;

ADULT; ADULT STEM CELLS; BETA CATENIN; CELL DIFFERENTIATION; DISEASE; HUMANS; WNT PROTEINS;

EID: 84923794490     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-014-9515-2     Document Type: Article

References (203)

1. Miki, T., Ring, A., & Gerlach, J. (2011). Hepatic differentiation of human embryonic stem cells is promoted by three-dimensional dynamic perfusion culture conditions. Tissue Engineering. Part C, Methods, 17(5), 557–68.
2. Jaenisch, R., & Young, R. (2008). Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell, 132(4), 567–82.
3. Trentin, A., Glavieux-Pardanaud, C., Le Douarin, N. M., & Dupin, E. (2004). Self-renewal capacity is a widespread property of various types of neural crest precursor cells. Proceedings of the National Academy of Sciences of the United States of America, 101(13), 4495–500.
4. Shyh-Chang, N., Daley, G. Q., & Cantley, L. C. (2013). Stem cell metabolism in tissue development and aging. Development, 140(12), 2535–47.
5. Ortiz-Gonzalez, X. R., Keene, C. D., Verfaillie, C. M., & Low, W. C. (2004). Neural induction of adult bone marrow and umbilical cord stem cells. Current Neurovascular Research, 1(3), 207–13.
6. Gage, F. H., & Temple, S. (2013). Neural stem cells: generating and regenerating the brain. Neuron, 80(3), 588–601.
7. Cullen, S. M., Mayle, A., Rossi, L., & Goodell, M. A. (2014). Hematopoietic stem cell development: an epigenetic journey. Current Topics in Developmental Biology, 107, 39–75.
8. Clevers, H. (2013). The intestinal crypt, a prototype stem cell compartment. Cell, 154(2), 274–84.
9. Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature, 414(6859), 105–11.
10. Miki, T., Yasuda, S. Y., & Kahn, M. (2011). Wnt/beta-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogramming. Stem Cell Reviews, 7(4), 836–46.
11. Takahashi-Yanaga, F., & Kahn, M. (2010). Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clinical Cancer Research, 16(12), 3153–62.
12. Merchant, A. A., & Matsui, W. (2010). Targeting hedgehog–a cancer stem cell pathway. Clinical Cancer Research, 16(12), 3130–40.
13. Liu, J., Sato, C., Cerletti, M., & Wagers, A. (2010). Notch signaling in the regulation of stem cell self-renewal and differentiation. Current Topics in Developmental Biology, 92, 367–409.
14. Takebe, N., Harris, P. J., Warren, R. Q., & Ivy, S. P. (2011). Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nature Reviews. Clinical Oncology, 8(2), 97–106.
15. Nusse, R. (2005). Wnt signaling in disease and in development. Cell Research, 15(1), 28–32.
16. MacDonald, B. T., Tamai, K., & He, X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Developmental Cell, 17(1), 9–26.
17. Klaus, A., & Birchmeier, W. (2008). Wnt signalling and its impact on development and cancer. Nature Reviews Cancer, 8(5), 387–98.
18. Gough NR. Focus issue: Wnt and beta-catenin signaling in development and disease. (2012) Sci Signal Jan 10;5 (206):eg2.
19. Fodde, R., & Brabletz, T. (2007). Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Current Opinion in Cell Biology, 19(2), 150–8.
20. Moon, R. T., Kohn, A. D., De Ferrari, G. V., & Kaykas, A. (2004). WNT and beta-catenin signalling: diseases and therapies. Nature Reviews Genetics, 5(9), 691–701.
21. Reya, T., & Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature, 434(7035), 843–50.
22. Dickinson, M. E., & McMahon, A. P. (1992). The role of Wnt genes in vertebrate development. Current Opinion in Genetics and Development, 2(4), 562–6.
23. Nusse, R., & Varmus, H. (2012). Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO Journal, 31(12), 2670–84.
24. Mlodzik, M. (2002). Planar cell polarization: do the same mechanisms regulate drosophila tissue polarity and vertebrate gastrulation? Trends in Genetics, 18(11), 564–71.
25. Wang, Y., & Nathans, J. (2007). Tissue/planar cell polarity in vertebrates: new insights and new questions. Development, 134(4), 647–58.
26. Veeman, M. T., Axelrod, J. D., & Moon, R. T. (2003). A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Developmental Cell, 5(3), 367–77.
27. Kohn, A. D., & Moon, R. T. (2005). Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium, 38(3–4), 439–46.
28. Florian, M. C., Nattamai, K. J., Dorr, K., Marka, G., Uberle, B., Vas, V., et al. (2013). A canonical to non-canonical Wnt signalling switch in haematopoietic stem-cell ageing. Nature, 503(7476), 392–6.
29. Nusse, R. (2008). Wnt signaling and stem cell control. Cell Research, 18(5), 523–7.
30. Nusse, R., & Varmus, H. E. (1992). Wnt genes. Cell, 69(7), 1073–87.
31. Moon RT. Wnt/beta-catenin pathway. (2005) Sci STKE 2005 Feb 15 (271):cm1.
32. Teo, J. L., & Kahn, M. (2010). The Wnt signaling pathway in cellular proliferation and differentiation: a tale of two coactivators. Advanced Drug Delivery Reviews, 62(12), 1149–55.
33. Daniels, D. L., & Weis, W. I. (2005). Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nature Structural and Molecular Biology, 12(4), 364–71.
34. Fang, M., Li, J., Blauwkamp, T., Bhambhani, C., Campbell, N., & Cadigan, K. M. (2006). C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila. EMBO Journal, 25(12), 2735–45.
35. Sampson, E. M., Haque, Z. K., Ku, M. C., Tevosian, S. G., Albanese, C., Pestell, R. G., et al. (2001). Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO Journal, 20(16), 4500–11.
36. Angers, S., & Moon, R. T. (2009). Proximal events in Wnt signal transduction. Nature Reviews Molecular Cell Biology, 10(7), 468–77.
37. Valenta, T., Hausmann, G., & Basler, K. (2012). The many faces and functions of beta-catenin. EMBO Journal, 31(12), 2714–36.
38. Zhang, N., Wei, P., Gong, A., Chiu, W. T., Lee, H. T., Colman, H., et al. (2011). FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell, 20(4), 427–42.
39. Tang, Y., Liu, Z., Zhao, L., Clemens, T. L., & Cao, X. (2008). Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion. Journal of Biological Chemistry, 283(35), 23956–63.
40. Liu, Z., Tang, Y., Qiu, T., Cao, X., & Clemens, T. L. (2006). A dishevelled-1/Smad1 interaction couples WNT and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells. Journal of Biological Chemistry, 281(25), 17156–63.
41. Saegusa, M., Hashimura, M., & Kuwata, T. (2012). Sox4 functions as a positive regulator of beta-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas. Laboratory Investigation, 92(4), 511–21.
42. Faunes, F., Hayward, P., Descalzo, S. M., Chatterjee, S. S., Balayo, T., Trott, J., et al. (2013). A membrane-associated beta-catenin/Oct4 complex correlates with ground-state pluripotency in mouse embryonic stem cells. Development, 140(6), 1171–83.
43. Scholtysek, C., Katzenbeisser, J., Fu, H., Uderhardt, S., Ipseiz, N., Stoll, C., et al. (2013). PPARbeta/delta governs Wnt signaling and bone turnover. Nature Medicine, 19(5), 608–13.
44. Dyson, H. J., & Wright, P. E. (2005). Intrinsically unstructured proteins and their functions. Nature Reviews Molecular Cell Biology, 6(3), 197–208.
45. Goodman, R. H., & Smolik, S. (2000). CBP/p300 in cell growth, transformation, and development. Genes and Development, 14(13), 1553–77.
46. Iyer, N. G., Ozdag, H., & Caldas, C. (2004). p300/CBP and cancer. Oncogene, 23(24), 4225–31.
47. Foley, P., Bunyan, D., Stratton, J., Dillon, M., & Lynch, S. A. (2009). Further case of Rubinstein-Taybi syndrome due to a deletion in EP300. American Journal of Medical Genetics Part A, 149A(5), 997–1000.
48. Yao, T. P., Oh, S. P., Fuchs, M., Zhou, N. D., Ch’ng, L. E., Newsome, D., et al. (1998). Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell, 93(3), 361–72.
49. Bedford, D. C., Kasper, L. H., Fukuyama, T., & Brindle, P. K. (2010). Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics, 5(1), 9–15.
50. Rebel, V. I., Kung, A. L., Tanner, E. A., Yang, H., Bronson, R. T., & Livingston, D. M. (2002). Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proceedings of the National Academy of Sciences of the United States of America, 99(23), 14789–94.
51. Roth, J. F., Shikama, N., Henzen, C., Desbaillets, I., Lutz, W., Marino, S., et al. (2003). Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5. EMBO Journal, 22(19), 5186–96.
52. Kawasaki, H., Eckner, R., Yao, T. P., Taira, K., Chiu, R., Livingston, D. M., et al. (1998). Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature, 393(6682), 284–9.
53. Ma, H., Nguyen, C., Lee, K. S., & Kahn, M. (2005). Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene, 24(22), 3619–31.
54. Siminovitch, L., McCulloch, E. A., & Till, J. E. (1963). The distribution of colony-forming cells among spleen colonies. Journal Cell Physiology, 62, 327–36.
55. Stachelscheid, H., Urbaniak, T., Ring, A., Spengler, B., Gerlach, J. C., & Zeilinger, K. (2009). Isolation and characterization of adult human liver progenitors from ischemic liver tissue derived from therapeutic hepatectomies. Tissue Engineering Part A, 15(7), 1633–43.
56. Lin, S. A., & Barker, N. (2011). Gastrointestinal stem cells in self-renewal and cancer. Journal of Gastroenterology, 46(9), 1039–55.
57. Leeman, K. T., Fillmore, C. M., & Kim, C. F. (2014). Lung stem and progenitor cells in tissue homeostasis and disease. Current Topics in Developmental Biology, 107C, 207–33.
58. Anversa, P., & Leri, A. (2013). Innate regeneration in the aging heart: healing from within. Mayo Clinic Proceedings, 88(8), 871–83.
59. Williams A. (2014) Central nervous system regeneration--where are we? QJM Jan 13.
60. Blanpain, C., & Simons, B. D. (2013). Unravelling stem cell dynamics by lineage tracing. Nature Reviews Molecular Cell Biology, 14(8), 489–502.
61. Ring, A., Gerlach, J., Peters, G., Pazin, B. J., Minervini, C. F., Turner, M. E., et al. (2010). Hepatic maturation of human fetal hepatocytes in four-compartment three-dimensional perfusion culture. Tissue Engineering. Part C, Methods, 16(5), 835–45.
62. Morrison, S. J., & Kimble, J. (2006). Asymmetric and symmetric stem-cell divisions in development and cancer. Nature, 441(7097), 1068–74.
63. Lowry, W. E., & Richter, L. (2007). Signaling in adult stem cells. Frontiers in Bioscience, 12, 3911–27.
64. Blank, U., Karlsson, G., & Karlsson, S. (2008). Signaling pathways governing stem-cell fate. Blood, 111(2), 492–503.
65. Boras-Granic, K., & Wysolmerski, J. J. (2008). Wnt signaling in breast organogenesis. Organogenesis, 4(2), 116–22.
66. Inestrosa, N. C., & Arenas, E. (2010). Emerging roles of Wnts in the adult nervous system. Nature Review Neuroscience, 11(2), 77–86.
67. Naito, A. T., Shiojima, I., Akazawa, H., Hidaka, K., Morisaki, T., Kikuchi, A., et al. (2006). Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America, 103(52), 19812–7.
68. Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., et al. (2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423(6938), 409–14.
69. Clarke, A. R. (2006). Wnt signalling in the mouse intestine. Oncogene, 25(57), 7512–21.
70. Brennan, K. R., & Brown, A. M. (2004). Wnt proteins in mammary development and cancer. Journal of Mammary Gland Biology and Neoplasia, 9(2), 119–31.
71. Zechner, D., Fujita, Y., Hulsken, J., Muller, T., Walther, I., Taketo, M. M., et al. (2003). beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Developmental Biology, 258(2), 406–18.
72. Korinek, V., Barker, N., & Moerer, P. (1998). van DE, Huls G, Peters PJ, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genetics, 19(4), 379–83.
73. Cheng, H., & Leblond, C. P. (1974). Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. unitarian theory of the origin of the four epithelial cell types. The American Journal of Anatomy, 141(4), 537–61.
74. Farin, H. F., van Es, J. H., & Clevers, H. (2012). Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology, 143(6), 1518–29.
75. Pinto, D., Gregorieff, A., Begthel, H., & Clevers, H. (2003). Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes and Development, 17(14), 1709–13.
76. Tian, H., Biehs, B., Warming, S., Leong, K. G., Rangell, L., Klein, O. D., et al. (2011). A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature, 478(7368), 255–9.
77. Yan, K. S., Chia, L. A., Li, X., Ootani, A., Su, J., Lee, J. Y., et al. (2012). The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proceedings of the National Academy of Sciences of the United States of America, 109(2), 466–71.
78. Barker, N., van Es, J. H., Kuipers, J., & Kujala, P. (2007). van den BM, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature, 449(7165), 1003–7.
79. De, L. W., Barker, N., Low, T. Y., Koo, B. K., Li, V. S., Teunissen, H., et al. (2011). Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature, 476(7360), 293–7.
80. Gregorieff, A., Pinto, D., Begthel, H., Destree, O., Kielman, M., & Clevers, H. (2005). Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology, 129(2), 626–38.
81. Sato, T., van Es, J. H., Snippert, H. J., Stange, D. E., Vries, R. G., van den, B. M., et al. (2011). Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature, 469(7330), 415–8.
82. Bastide, P., Darido, C., Pannequin, J., Kist, R., Robine, S., Marty-Double, C., et al. (2007). Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. Journal of Cell Biology, 178(4), 635–48.
83. Mori-Akiyama, Y., van den, B. M., van Es, J. H., Hamilton, S. R., Adams, H. P., Zhang, J., et al. (2007). SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology, 133(2), 539–46.
84. Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., et al. (2003). Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature, 423(6938), 448–52.
85. Nemeth, M. J., Mak, K. K., Yang, Y., & Bodine, D. M. (2009). Beta-Catenin expression in the bone marrow microenvironment is required for long-term maintenance of primitive hematopoietic cells. Stem Cells, 27(5), 1109–19.
86. Malhotra, S., & Kincade, P. W. (2009). Wnt-related molecules and signaling pathway equilibrium in hematopoiesis. Cell Stem Cell, 4(1), 27–36.
87. Fukuda, S., & Pelus, L. M. (2001). Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34 (+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood, 98(7), 2091–100.
88. Fukuda, S., Foster, R. G., Porter, S. B., & Pelus, L. M. (2002). The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34 (+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood, 100(7), 2463–71.
89. Dravid, G., Ye, Z., Hammond, H., Chen, G., Pyle, A., Donovan, P., et al. (2005). Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells, 23(10), 1489–501.
90. Gessert, S., & Kuhl, M. (2010). The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circulation Research, 107(2), 186–99.
91. Brade, T., Manner, J., & Kuhl, M. (2006). The role of Wnt signalling in cardiac development and tissue remodelling in the mature heart. Cardiovascular Research, 72(2), 198–209.
92. Baurand, A., Zelarayan, L., Betney, R., Gehrke, C., Dunger, S., Noack, C., et al. (2007). Beta-catenin downregulation is required for adaptive cardiac remodeling. Circulation Research, 100(9), 1353–62.
93. mini-Nik, S., Glancy, D., Boimer, C., Whetstone, H., Keller, C., & Alman, B. A. (2011). Pax7 expressing cells contribute to dermal wound repair, regulating scar size through a beta-catenin mediated process. Stem Cells, 29(9), 1371–9.
94. Saraswati, S., Alfaro, M. P., Thorne, C. A., Atkinson, J., Lee, E., & Young, P. P. (2010). Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling. PLoS One, 5(11), e15521.
95. Sasaki, T., Hwang, H., Nguyen, C., Kloner, R. A., & Kahn, M. (2013). The small molecule Wnt signaling modulator ICG-001 improves contractile function in chronically infarcted rat myocardium. PLoS One, 8(9), e75010.
96. Zeng, Y. A., & Nusse, R. (2010). Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell, 6(6), 568–77.
97. Turashvili, G., Bouchal, J., Burkadze, G., & Kolar, Z. (2006). Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology, 73(5), 213–23.
98. Imbert, A., Eelkema, R., Jordan, S., Feiner, H., & Cowin, P. (2001). Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. Journal of Cell Biology, 153(3), 555–68.
99. Liu, B. Y., McDermott, S. P., Khwaja, S. S., & Alexander, C. M. (2004). The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proceedings of the National Academy of Sciences of the United States of America, 101(12), 4158–63.
100. Tepera, S. B., McCrea, P. D., & Rosen, J. M. (2003). A beta-catenin survival signal is required for normal lobular development in the mammary gland. Journal of Cell Science, 116(Pt 6), 1137–49.
101. Hsu, W., Shakya, R., & Costantini, F. (2001). Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice. Journal of Cell Biology, 155(6), 1055–64.
102. Boras-Granic, K., Chang, H., Grosschedl, R., & Hamel, P. A. (2006). Lef1 is required for the transition of Wnt signaling from mesenchymal to epithelial cells in the mouse embryonic mammary gland. Developmental Biology, 295(1), 219–31.
103. Alexander CM, Goel S, Fakhraldeen SA, Kim S. (2012) Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling. Cold Spring Harb Perspect Biol;4 (10).
104. Kordon, E. C., & Smith, G. H. (1998). An entire functional mammary gland may comprise the progeny from a single cell. Development, 125(10), 1921–30.
105. Badders, N. M., Goel, S., Clark, R. J., Klos, K. S., Kim, S., Bafico, A., et al. (2009). The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage. PLoS One, 4(8), e6594.
106. Lindvall, C., Zylstra, C. R., Evans, N., West, R. A., Dykema, K., Furge, K. A., et al. (2009). The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. PLoS One, 4(6), e5813.
107. Wexler, E. M., Paucer, A., Kornblum, H. I., Palmer, T. D., & Geschwind, D. H. (2009). Endogenous Wnt signaling maintains neural progenitor cell potency. Stem Cells, 27(5), 1130–41.
108. Fancy, S. P., Harrington, E. P., Yuen, T. J., Silbereis, J. C., Zhao, C., Baranzini, S. E., et al. (2011). Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nature Neuroscience, 14(8), 1009–16.
109. Teo, J. L., Ma, H., Nguyen, C., Lam, C., & Kahn, M. (2005). Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation. Proceedings of the National Academy of Sciences of the United States of America, 102(34), 12171–6.
110. Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., et al. (2007). Molecular definition of breast tumor heterogeneity. Cancer Cell, 11(3), 259–73.
111. Visvader, J. E., & Lindeman, G. J. (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer, 8(10), 755–68.
112. Al-Hajj, M., & Clarke, M. F. (2004). Self-renewal and solid tumor stem cells. Oncogene, 23(43), 7274–82.
113. Jamieson, C. H., Weissman, I. L., & Passegue, E. (2004). Chronic versus acute myelogenous leukemia: a question of self-renewal. Cancer Cell, 6(6), 531–3.
114. Armanios, M., & Greider, C. W. (2005). Telomerase and cancer stem cells. Cold Spring Harbor Symposia on Quantitative Biology, 70, 205–8.
115. Clevers, H. (2011). The cancer stem cell: premises, promises and challenges. Nature Medicine, 17(3), 313–9.
116. Visvader, J. E., & Lindeman, G. J. (2010). Stem cells and cancer - the promise and puzzles. Molecular Oncology, 4(5), 369–72.
117. Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Goodell, M. A., & Brenner, M. K. (2005). A distinct “side population” of cells in human tumor cells: implications for tumor biology and therapy. Cell Cycle, 4(2), 203–5.
118. Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., et al. (2004). A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 101(39), 14228–33.
119. Hussenet, T., Dembele, D., Martinet, N., Vignaud, J. M., & du, M. S. (2010). An adult tissue-specific stem cell molecular phenotype is activated in epithelial cancer stem cells and correlated to patient outcome. Cell Cycle, 9(2), 321–7.
120. Liu, S., & Wicha, M. S. (2010). Targeting breast cancer stem cells. Journal of Clinical Oncology, 28(25), 4006–12.
121. Vassiliou, G. S., Cooper, J. L., Rad, R., Li, J., Rice, S., Uren, A., et al. (2011). Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice. Nature Genetics, 43(5), 470–5.
122. Gudjonsson, T., & Magnusson, M. K. (2005). Stem cell biology and the cellular pathways of carcinogenesis. APMIS, 113(11–12), 922–9.
123. Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., et al. (2011). Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proceedings of the National Academy of Sciences of the United States of America, 108(19), 7950–5.
124. Liu, S., Ginestier, C., Charafe-Jauffret, E., Foco, H., Kleer, C. G., Merajver, S. D., et al. (2008). BRCA1 regulates human mammary stem/progenitor cell fate. Proceedings of the National Academy of Sciences of the United States of America, 105(5), 1680–5.
125. Foulkes, W. D. (2004). BRCA1 functions as a breast stem cell regulator. Journal of Medical Genetics, 41(1), 1–5.
126. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704–15.
127. Morel, A. P., Lievre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008). Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One, 3(8), e2888.
128. der PG, v. (2011). Epithelial plasticity, cancer stem cells and bone metastasis formation. Bone, 48(1), 37–43.
129. Godde, N. J., Galea, R. C., Elsum, I. A., & Humbert, P. O. (2010). Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions. Journal of Mammary Gland Biology and Neoplasia, 15(2), 149–68.
130. Chaffer, C. L., & Weinberg, R. A. (2011). A perspective on cancer cell metastasis. Science, 331(6024), 1559–64.
131. Moreno-Bueno, G., Portillo, F., & Cano, A. (2008). Transcriptional regulation of cell polarity in EMT and cancer. Oncogene, 27(55), 6958–69.
132. Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L., & Strasser, A. (2007). Tumor growth need not be driven by rare cancer stem cells. Science, 317(5836), 337.
133. Bruce, W., & Van Der, G. (1963). A quantitative assay for the Number of murine lymphoma cells capable of proliferation in vivo. Nature, 199, 79–80.
134. Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3(7), 730–7.
135. Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., et al. (2004). Identification of human brain tumour initiating cells. Nature, 432(7015), 396–401.
136. Fang, D., Nguyen, T. K., Leishear, K., Finko, R., Kulp, A. N., Hotz, S., et al. (2005). A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Research, 65(20), 9328–37.
137. Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., et al. (2007). Identification of pancreatic cancer stem cells. Cancer Research, 67(3), 1030–7.
138. Ma, S., Chan, K. W., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., et al. (2007). Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology, 132(7), 2542–56.
139. O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445(7123), 106–10.
140. Blum, B., Bar-Nur, O., Golan-Lev, T., & Benvenisty, N. (2009). The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nature Biotechnology, 27(3), 281–7.
141. Hoffmeyer, K., Raggioli, A., Rudloff, S., Anton, R., Hierholzer, A., Del, V. I., et al. (2012). Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science, 336(6088), 1549–54.
142. DiMeo, T. A., Anderson, K., Phadke, P., Fan, C., Perou, C. M., Naber, S., et al. (2009). A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Research, 69(13), 5364–73.
143. Sack, U., Walther, W., Scudiero, D., Selby, M., Aumann, J., Lemos, C., et al. (2011). S100A4-induced cell motility and metastasis is restricted by the Wnt/beta-catenin pathway inhibitor calcimycin in colon cancer cells. Molecular Biology of the Cell, 22(18), 3344–54.
144. Uchino, M., Kojima, H., Wada, K., Imada, M., Onoda, F., Satofuka, H., et al. (2010). Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells. BMC Cancer, 10, 414.
145. Yu, M., Ting, D. T., Stott, S. L., Wittner, B. S., Ozsolak, F., Paul, S., et al. (2012). RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature, 487(7408), 510–3.
146. Lickert, H., Domon, C., Huls, G., Wehrle, C., Duluc, I., Clevers, H., et al. (2000). Wnt/(beta)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development, 127(17), 3805–13.
147. Russell, R. G., Lasorella, A., Dettin, L. E., & Iavarone, A. (2004). Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium. Cancer Research, 64(20), 7220–5.
148. Klonisch, T., Wiechec, E., Hombach-Klonisch, S., Ande, S. R., Wesselborg, S., Schulze-Osthoff, K., et al. (2008). Cancer stem cell markers in common cancers - therapeutic implications. Trends in Molecular Medicine, 14(10), 450–60.
149. Wielenga, V. J., Smits, R., Korinek, V., Smit, L., Kielman, M., Fodde, R., et al. (1999). Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. American Journal of Pathology, 154(2), 515–23.
150. Shulewitz, M., Soloviev, I., Wu, T., Koeppen, H., Polakis, P., & Sakanaka, C. (2006). Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer. Oncogene, 25(31), 4361–9.
151. Katoh, Y., & Katoh, M. (2007). Comparative genomics on PROM1 gene encoding stem cell marker CD133. International Journal of Molecular Medicine, 19(6), 967–70.
152. Correa, S., Binato, R., Du, R. B., Castelo-Branco, M. T., Pizzatti, L., & Abdelhay, E. (2012). Wnt/beta-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia. BMC Cancer, 12, 303.
153. Yamada, T., Takaoka, A. S., Naishiro, Y., Hayashi, R., Maruyama, K., Maesawa, C., et al. (2000). Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Research, 60(17), 4761–6.
154. Munz, M., Baeuerle, P. A., & Gires, O. (2009). The emerging role of EpCAM in cancer and stem cell signaling. Cancer Research, 69(14), 5627–9.
155. Yamashita, T., Budhu, A., Forgues, M., & Wang, X. W. (2007). Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Research, 67(22), 10831–9.
156. Al-Hajj, M., Wicha, M. S., ito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 100(7), 3983–8.
157. Sheridan, C., Kishimoto, H., Fuchs, R. K., Mehrotra, S., Bhat-Nakshatri, P., Turner, C. H., et al. (2006). CD44+/. Breast Cancer Research, 8(5), R59.
158. Fillmore, C. M., & Kuperwasser, C. (2008). Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Research, 10(2), R25.
159. Hennessy, B. T., Gonzalez-Angulo, A. M., Stemke-Hale, K., Gilcrease, M. Z., Krishnamurthy, S., Lee, J. S., et al. (2009). Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Research, 69(10), 4116–24.
160. Nusse, R., & Varmus, H. E. (1982). Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell, 31(1), 99–109.
161. Howe, L. R., & Brown, A. M. (2004). Wnt signaling and breast cancer. Cancer Biology and Therapy, 3(1), 36–41.
162. Mukherjee, N., Bhattacharya, N., Alam, N., Roy, A., Roychoudhury, S., & Panda, C. K. (2012). Subtype-specific alterations of the Wnt signaling pathway in breast cancer: clinical and prognostic significance. Cancer Science, 103(2), 210–20.
163. Khramtsov, A. I., Khramtsova, G. F., Tretiakova, M., Huo, D., Olopade, O. I., & Goss, K. H. (2010). Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. American Journal of Pathology, 176(6), 2911–20.
164. Lim, E., Wu, D., Pal, B., & Bouras, T. (2010). sselin-Labat ML, Vaillant F, et al. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Research, 12(2), R21.
165. Zhang, Y., Toy, K. A., & Kleer, C. G. (2012). Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition. Modern Pathology, 25(2), 178–84.
166. Howe, L. R., Watanabe, O., Leonard, J., & Brown, A. M. (2003). Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Research, 63(8), 1906–13.
167. Takebe, N., Warren, R. Q., & Ivy, S. P. (2011). Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Research, 13(3), 211.
168. Bhat-Nakshatri, P., Appaiah, H., Ballas, C., Pick-Franke, P., Goulet, R., Jr., Badve, S., et al. (2010). SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer, 10, 411.
169. Wang, J., O’Bara, M. A., Pol, S. U., & Sim, F. J. (2013). CD133/CD140a-based isolation of distinct human multipotent neural progenitor cells and oligodendrocyte progenitor cells. Stem Cells and Development, 22(15), 2121–31.
170. Shmelkov, S. V., St, C. R., Lyden, D., & Rafii, S. (2005). AC133/CD133/Prominin-1. International Journal of Biochemistry and Cell Biology, 37(4), 715–9.
171. Corbeil, D., Marzesco, A. M., Wilsch-Brauninger, M., & Huttner, W. B. (2010). The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro) epithelial cell differentiation. FEBS Letters, 584(9), 1659–64.
172. Yin, A. H., Miraglia, S., & Zanjani, E. D. (1997). meida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90(12), 5002–12.
173. Uchida, H., Yamazaki, K., Fukuma, M., Yamada, T., Hayashida, T., Hasegawa, H., et al. (2010). Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Science, 101(7), 1731–7.
174. Vermeulen, L., Todaro, M., de Sousa, M. F., Sprick, M. R., Kemper, K., Perez, A. M., et al. (2008). Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proceedings of the National Academy of Sciences of the United States of America, 105(36), 13427–32.
175. van de, W. M., Sancho, E., Verweij, C., de, L. W., Oving, I., Hurlstone, A., et al. (2002). The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111(2), 241–50.
176. Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G. F., et al. (2006). Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells, 24(3), 506–13.
177. Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., et al. (2004). A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 101(39), 14228–33.
178. O’Brien, C. A., Kreso, A., & Jamieson, C. H. (2010). Cancer stem cells and self-renewal. Clinical Cancer Research, 16(12), 3113–20.
179. Moshaver, B. (2008). van RA, Kelder A, van der PM, Terwijn M, Bachas C, et al. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia. Stem Cells, 26(12), 3059–67.
180. Wang, Y., Krivtsov, A. V., Sinha, A. U., North, T. E., Goessling, W., Feng, Z., et al. (2010). The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science, 327(5973), 1650–3.
181. Radich, J. P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., et al. (2006). Gene expression changes associated with progression and response in chronic myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America, 103(8), 2794–9.
182. Pehlivan, M., Sercan, Z., & Sercan, H. O. (2009). sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia. Leukemia Research, 33(8), 1062–7.
183. Gang EJ, Hsieh YT, Pham J, Zhao Y, Nguyen C, Huantes S, et al. (2013) Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia. Oncogene Jun 3.
184. Cavodeassi, F., Carreira-Barbosa, F., Young, R. M., Concha, M. L., Allende, M. L., Houart, C., et al. (2005). Early stages of zebrafish eye formation require the coordinated activity of Wnt11, Fz5, and the Wnt/beta-catenin pathway. Neuron, 47(1), 43–56.
185. Rudloff, S., & Kemler, R. (2012). Differential requirements for beta-catenin during mouse development. Development, 139(20), 3711–21.
186. Otto, A., Schmidt, C., Luke, G., Allen, S., Valasek, P., Muntoni, F., et al. (2008). Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. Journal of Cell Science, 121(Pt 17), 2939–50.
187. Le, G. F., Jones, A. E., Seale, V., Scime, A., & Rudnicki, M. A. (2009). Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell, 4(6), 535–47.
188. Otero, J. J., Fu, W., Kan, L., Cuadra, A. E., & Kessler, J. A. (2004). Beta-catenin signaling is required for neural differentiation of embryonic stem cells. Development, 131(15), 3545–57.
189. Wang, X., Kopinke, D., Lin, J., McPherson, A. D., Duncan, R. N., Otsuna, H., et al. (2012). Wnt signaling regulates postembryonic hypothalamic progenitor differentiation. Developmental Cell, 23(3), 624–36.
190. Chenn, A., & Walsh, C. A. (2002). Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science, 297(5580), 365–9.
191. Li, J., Sutter, C., Parker, D. S., Blauwkamp, T., Fang, M., & Cadigan, K. M. (2007). CBP/p300 are bimodal regulators of Wnt signaling. EMBO Journal, 26(9), 2284–94.
192. Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., et al. (2004). A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proceedings of the National Academy of Sciences of the United States of America, 101(34), 12682–7.
193. McMillan, M., & Kahn, M. (2005). Investigating Wnt signaling: a chemogenomic safari. Drug Discovery Today, 10(21), 1467–74.
194. Kumar, S. R., Scehnet, J. S., Ley, E. J., Singh, J., Krasnoperov, V., Liu, R., et al. (2009). Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Research, 69(9), 3736–45.
195. Kim, Y. M., Ma, H., Oehler, V. G., Gang, E. J., Nguyen, C., Masiello, D., et al. (2011). The gamma catenin/CBP complex maintains survivin transcription in beta-catenin deficient/depleted cancer cells. Current Cancer Drug Targets, 11(2), 213–25.
196. Deato, M. D., & Tjian, R. (2008). An unexpected role of TAFs and TRFs in skeletal muscle differentiation: switching core promoter complexes. Cold Spring Harbor Symposia on Quantitative Biology, 73, 217–25.
197. Creyghton, M. P., Roel, G., Eichhorn, P. J., Hijmans, E. M., Maurer, I., Destree, O., et al. (2005). PR72, a novel regulator of Wnt signaling required for naked cuticle function. Genes and Development, 19(3), 376–86.
198. Zeng, W., Wharton, K. A., Jr., Mack, J. A., Wang, K., Gadbaw, M., Suyama, K., et al. (2000). naked cuticle encodes an inducible antagonist of Wnt signalling. Nature, 403(6771), 789–95.
199. Miyabayashi, T., Teo, J. L., Yamamoto, M., McMillan, M., Nguyen, C., & Kahn, M. (2007). Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proceedings of the National Academy of Sciences of the United States of America, 104(13), 5668–73.
200. Hasegawa, K., Yasuda, S. Y., Teo, J. L., Nguyen, C., McMillan, M., Hsieh, C. L., et al. (2012). Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion. Stem Cells Translational Medecine, 1(1), 18–28.
201. Corcoran, E. E., Joseph, J. D., MacDonald, J. A., Kane, C. D., Haystead, T. A., & Means, A. R. (2003). Proteomic analysis of calcium/calmodulin-dependent protein kinase I and IV in vitro substrates reveals distinct catalytic preferences. Journal of Biological Chemistry, 278(12), 10516–22.
202. Cicalese, A., Bonizzi, G., Pasi, C. E., Faretta, M., Ronzoni, S., Giulini, B., et al. (2009). The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell, 138(6), 1083–95.
203. Cohnheim, J. (1867). Ueber entzuendung und eiterung. PathologyAnatomyPhysiologyKlinicheskaia Meditsina, 40, 1–79.